Literature DB >> 19228350

PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar.

Narayan Raj Bhattarai1, Gert Van der Auwera, Basudha Khanal, Simonne De Doncker, Suman Rijal, Murari Lal Das, Surendra Uranw, Bart Ostyn, Nicolas Praet, Niko Speybroeck, Albert Picado, Clive Davies, Marleen Boelaert, Jean-Claude Dujardin.   

Abstract

OBJECTIVE: To compare a PCR assay and direct agglutination test (DAT) for the detection of potential markers of Leishmania infection in 231 healthy subjects living in a kala-azar endemic focus of Nepal.
METHODS: The sample was composed of 184 (80%) persons without any known history of KA and not living in the same house as known kala-azar cases (HNK), 24 (10%) Healthy Household Contacts (HHC) and 23 (10%) past kala-azar cases which had been successfully treated (HPK).
RESULTS: PCR and DAT positivity scores were, respectively: HNK, 17.6% and 5.6%; HHC, 12.5% and 20.8%; HPK, 26.1% and 95.7%. The ratio PCR-positives/DAT-positives was significantly higher in HNK (ratio = 3.1) than in HHC (ratio = 0.6, P = 0.036) and in HPK (ratio = 0.2, P = 0.012). The ratio PCR-positives/DAT-positives did not significantly differ between HHC (ratio = 0.6) and HPK (ratio = 0.2, P = 0.473). The positive agreement index between PCR and DAT in HNK was 5%; in HHC, 0%; in HPK, 43%.
CONCLUSIONS: Our study highlights the specific character of PCR and DAT for the exploration of Leishmania asymptomatic infections. PCR is probably more informative for very recent infections among HNK, while DAT provides more information among HHC and HPK, a feature likely related to the power of serology to track less recent infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228350     DOI: 10.1111/j.1365-3156.2009.02242.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  24 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 2.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

3.  Infection with versus exposure to Taenia solium: what do serological test results tell us?

Authors:  Nicolas Praet; Richar Rodriguez-Hidalgo; Niko Speybroeck; Serge Ahounou; Washington Benitez-Ortiz; Dirk Berkvens; Anke Van Hul; Margoth Barrionuevo-Samaniego; Claude Saegerman; Pierre Dorny
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

4.  Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India.

Authors:  Kamlesh Gidwani; Albert Picado; Bart Ostyn; Shri Prakash Singh; Rajiv Kumar; Basudha Khanal; Veerle Lejon; François Chappuis; Marleen Boelaert; Shyam Sundar
Journal:  Clin Vaccine Immunol       Date:  2010-12-15

5.  Serological and Molecular Analysis of Leishmania Infection in Healthy Individuals from Two Districts of West Bengal, India, Endemic for Visceral Leishmaniasis.

Authors:  Himanshu Kaushal; Sujit Kumar Bhattacharya; Sandeep Verma; Poonam Salotra
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

Review 6.  Molecular Diagnosis of Visceral Leishmaniasis.

Authors:  Shyam Sundar; Om Prakash Singh
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

7.  Asymptomatic Leishmania infection: a new challenge for Leishmania control.

Authors:  Om Prakash Singh; Epco Hasker; David Sacks; Marleen Boelaert; Shyam Sundar
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

8.  Domestic animals and epidemiology of visceral leishmaniasis, Nepal.

Authors:  Narayan Raj Bhattarai; Gert Van der Auwera; Suman Rijal; Albert Picado; Niko Speybroeck; Basudha Khanal; Simonne De Doncker; Murari Lal Das; Bart Ostyn; Clive Davies; Marc Coosemans; Dirk Berkvens; Marleen Boelaert; Jean Claude Dujardin
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

9.  Diagnostic accuracy of the Leishmania OligoC-TesT and NASBA-Oligochromatography for diagnosis of leishmaniasis in Sudan.

Authors:  Alfarazdeg A Saad; Nuha G Ahmed; Osman S Osman; Ahmed Almustafa Al-Basheer; Awad Hamad; Stijn Deborggraeve; Philippe Büscher; Gerard J Schoone; Henk D Schallig; Thierry Laurent; Ahmed Haleem; Omran F Osman; Ahmed Mohamedain Eltom; Mustafa I Elbashir; Sayda El-Safi
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

10.  Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.

Authors:  A C Vallur; M S Duthie; C Reinhart; Y Tutterrow; S Hamano; K R H Bhaskar; R N Coler; D Mondal; S G Reed
Journal:  Clin Microbiol Infect       Date:  2013-11-18       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.